RUCO, Luigi
 Distribuzione geografica
Continente #
NA - Nord America 7.417
EU - Europa 1.953
AS - Asia 1.101
SA - Sud America 54
AF - Africa 37
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.567
Nazione #
US - Stati Uniti d'America 7.360
IT - Italia 508
SE - Svezia 497
SG - Singapore 432
IN - India 383
CN - Cina 238
FI - Finlandia 230
UA - Ucraina 227
IE - Irlanda 138
DE - Germania 81
GB - Regno Unito 77
CA - Canada 51
AR - Argentina 46
RU - Federazione Russa 39
BG - Bulgaria 37
NL - Olanda 27
RO - Romania 27
TG - Togo 25
BE - Belgio 19
FR - Francia 18
KR - Corea 11
TR - Turchia 11
CH - Svizzera 10
BR - Brasile 6
ES - Italia 6
ID - Indonesia 6
JP - Giappone 6
ZA - Sudafrica 6
HK - Hong Kong 5
MX - Messico 5
IR - Iran 4
AT - Austria 3
LT - Lituania 3
SC - Seychelles 3
AL - Albania 2
AU - Australia 2
EU - Europa 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
Totale 10.567
Città #
Fairfield 1.300
Woodbridge 562
Ashburn 550
Chandler 540
Houston 483
Seattle 477
Cambridge 421
Wilmington 389
Singapore 298
Ann Arbor 282
San Paolo di Civitate 254
Princeton 211
Plano 207
Lawrence 172
Beijing 152
Dublin 138
Dearborn 117
Rome 114
Millbury 106
Jacksonville 97
Santa Clara 97
Boston 93
San Diego 81
Andover 54
Fremont 52
Des Moines 49
Boardman 48
Federal 46
Helsinki 41
Sofia 37
Toronto 37
Norwalk 35
Falls Church 26
Lomé 25
Stockholm 20
London 18
Moscow 18
Brussels 16
New York 15
Falkenstein 14
Mannheim 14
Bühl 12
Kunming 12
Paris 12
Bremen 11
Fasano 11
Bern 10
Istanbul 10
Los Angeles 10
Auburn Hills 9
Grafing 9
Hefei 9
Nanjing 9
Ottawa 8
Chicago 7
Indiana 7
Buffalo 6
Jakarta 6
Milan 6
Pune 6
Tokyo 6
Columbia 5
Montréal 5
Parma 5
Phoenix 5
San Jose 5
San Mateo 5
Southend 5
Edinburgh 4
Frankfurt am Main 4
Jinan 4
Nuremberg 4
Pozzuoli 4
Redmond 4
Tappahannock 4
Turin 4
Wuhan 4
Barcelona 3
Bari 3
Cernusco sul Naviglio 3
Dallas 3
Fuzhou 3
Gateshead 3
Genoa 3
Homburg 3
Kilburn 3
Laurel 3
Mexico City 3
Muizenberg 3
Nanchang 3
Naples 3
Philadelphia 3
Pinto 3
Romola 3
Springfield 3
Waanrode 3
Washington 3
Atlanta 2
Boydton 2
Casalecchio di Reno 2
Totale 8.019
Nome #
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ 112
Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas 109
CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation 99
Cystic lymphoepithelial lesions of the parotid gland in HIV-1 infection 98
Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma 97
Epstein-Barr virus–positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus–positive diffuse large B-cell lymphoma of the elderly 96
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients 95
Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung Cancer 92
A case of sinonasal melanoma with unusual primary Exon 17 KIT D820G mutation 89
The prognostic implication of thymoma histologic subtyping. A study of 80 consecutive cases 88
Transglutaminase type II plays a protective role in hepatic injury 87
Clinical and antitumor immune responses In Relapsed/Refractory Follicular Lymphoma patients after intranodal injections of IFNα-Dendritic Cells and Rituximab 87
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer 85
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy 85
Lymph node ratio is a stronger prognotic factor than microsatellite instability in colorectal cancer patients: Results from a 7 years follow-up study 84
Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro 83
Severe and prolonged myelosuppression during concomitant temozolomide and radiotherapy treatment in a patient with glioblastoma multiforme 83
Spheres derived from lung adenocarcinoma pleural effusions: Molecular characterization and tumor engraftment 82
The lymphoepithelial organization of the tonsil: an immunohistochemical chronic recurrent tonsillitis 80
Peripheral T cell lymphoma with cytotoxic phenotype: An emerging disease in HIV infected patients ? 80
Hairy cell leukemia: absence of natural killer activity and of interleukin 1 release in OKM-1+ spleen hairy cells. 79
Reduced lymphotoxin-beta production by tumour cells is associated with loss of follicular dendritic cell phenotype and diffuse growth in follicular lymphoma 78
Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active anti-retroviral therapy 78
Left-sided early-onset vs late-onset colorectal carcinoma: histologic, clinical, and molecular differences 78
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin’s lymphomas 77
B- and T-cell non-Hodgkin's lymphomas with large multilobated cells: morphological, phenotypic and clinical heterogeneity. 77
CD4(+)/CD56(+) hematodermic neoplasm 77
Expression of VE(Vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas 76
Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions 75
THE ORIGIN AND FUNCTION OF TUMOR-ASSOCIATED MACROPHAGES 75
True thymic hyperplasia associated with thymic hemorrhage in an adult patient 75
Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization 74
Distinct Phenotypic and Functional Immunological Alterations Characterize the Peripheral Blood Compartment of Patients with Diffuse Large B Cell Lymphoma (DLBCL) 74
Left-sided early onset colorectal carcinomas: a sporadic neoplasm with aggressive behavior 74
Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation. 73
EGFR mutation testing in pulmonary adenocarcinoma. Evaluation of tumor cell number and tumor percent in paraffin sections of 120 small biopsies 73
Burkitt lymphoma in Iraqi children. A distinctive form of sporadic disease with high incidence of EBV+cases and more frequent expression of MUM1/IRF4 protein in cases with head and neck presentation 73
ANALYSIS OF PROGNOSTIC FACTORS AND CLINICOPATHOLOGICAL STAGING OF THYMOMA 72
Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum 72
Detection of HIV-1 genome in lymph-node biopsies by polymerase chain reaction: a useful tool for epidemiological studies. 72
COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness 72
Adrenocorticotropic hormone-secreting ganglioneuroblastoma associated with opsomyoclonic encephalopathy: a case report with immunohistochemical study. 71
Association of diffuse liver glycogenosis and mild focal macrovesicular steatosis in a patient with poorly controlled type 1 diabetes 70
B cell clonality in multiple localisation of primary central nervous system lymphomas in AIDS patients 70
Thrombospondin-1 inhibits Kaposi’s sarcoma (KS) cell and HIV-1 TAT induced angiogenesis and is poorly expressed in KS lesions 70
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses 69
Monocyte chemotactic protein-1 in the inflammatory pseudotumour of the lung 68
'Organoid' thymoma: a well-differentiated variant with distinctive clinicopathological features 68
A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells. 68
Expression of adhesion molecules and extracellular matrix proteins in glioblastomas: Relation to angiogenesis and spread 68
Continuous intra-arterial administration of recombinant interleukin-2 in low-stage bladder cancer: a phase IB study. 67
Low antibody responsiveness to T-dependent antigens in C3H/HeJ mice. 67
Soluble and cell-associated IL-2 receptor (IL-2R) after local immunotherapy with recombinant interleukin-2 (rIL-2). 67
Study of histopathologic parameters to define the prognosis of stage II colon cancer 67
Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): case report with nodal and diffuse muco-cutaneous involvement 66
Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with downregulation of VEGF-D production by tumour cells 66
Papillary carcinoma of the thyroid: evidence for a role of hepatocyte growth factor (HGF) in promoting tumour angiogenesis 66
Acute megakaryoblastic leucemia in a patient receiving HAART 65
Phenotypic And Functional Long-Term Dynamics Of Peripheral Blood Natural Killer Cell Compartment In Diffuse-Large-B-Cell Lymphoma Patients Before And After R-Chop-Based Immunochemotherapy 65
High prevalence of ALK+/ROS1+ cases in pulmonary adenocarcinoma of adoloscents and young adults 65
Primary malignant tumour of the lung with neuroendocrine and melanoma differentiation 64
Defective helper T-cell activity in LPS-unresponsive C3H/HeJ mice. 64
Characterization of EN4 monoclonal antibody: a reagent with CD31 specificity. 64
Characterization of macrophage activation factor, a lymphokine that causes macrophages to become cytotoxic for tumor cells 64
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients 64
T-lymphocyte subsets in human lymph nodes: Relative increase of OKT-8+ cells in neoplastic and reactive B-cell proliferation 64
Tissue cutting by ultrashort pulses from a Ti-zaffire laser system: Strong reduction of thermal alteration around the cutting line 64
Adhesion molecules and lymphocyte recruitment in lymphocytic thyroiditis, thyroid papillary carcinoma and parotid adenolymphoma. 64
The peripheral blood compartment of patients with Diffuse Large B Cell Lymphoma (DLBCL) at diagnosis is characterized by distinct phenotypic and functional Immunological alterations 64
Clinical and immunological findings in four infants with Omenn's syndrome: a form of severe combined immunodeficiency with phenotypically normal T cells, elevated IgE, and eosinophilia. 64
Clinical, pathological and molecular features of early onset 63
Detection of adhesion molecules by immunohistochemistry on human and murine tissue sections. 63
Peripheral T cell lymphoma in adults: Morphological and phenotypical study of four cases 63
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. 62
Iatrogenic EBV-positive lymphoproliferative disorder with features of EBV+ mucocutaneous ulcer: Evidence for concomitant TCRγ/IGH rearrangements in the Hodgkin-like neoplastic cells 62
Increased monocyte phagocytosis in cancer patients. 62
Optimized immunohistochemistry using the D5F3 antibody provides a reliable test for identification of ALK-positive lung adenocarcinomas 62
A novel endothelial-specific membrane protein is a marker of cell-cell contacts. 62
Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) antigens and genome in lymph nodes of HIV-positive patients affected by persistent generalized lymphadenopathy (PGL). 62
Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice. 61
External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale 61
In vitro formation of eosinophil-like colonies by lymph node cells from a human lymphoma. 60
HIGH-FREQUENCY OF EPSTEIN-BARR VIRUS GENOME IN HIV-POSITIVE PATIENTS WITH HODGKINS-DISEASE 60
Multidisciplinary approach to fetal adenocarcinoma of the lung: A case report 60
Papillary carcinoma of the thyroid: Methylation is not involved in the regulation of MET expression 60
Follicular dendritic cells display microvesicle-associated LMP1 in reactive germinal centers of EBV+ classic Hodgkin lymphoma 60
Tissue T-lymphocytes in untreated Hodgkin's disease: morphologic and functional correlations in spleens and lymph nodes. 59
S-100+ lymph node neoplasm. Report of a case with histological AL and immunological features intermediate between T cell lymphoma and malignant histiocytosis. 59
Macrophage activation for tumor cytotoxicity: reactivity of peritoneal and bone marrow macrophages. 58
The Omenn's syndrome: histological, immunohistochemical and ultrastructural evidence for a partial T cell deficiency evolving in an abnormal proliferation of T lymphocytes and S-100 +/T-6 + Langerhans-like cells. 58
Immunohistochemical demonstration of p24 HTLV III major core protein in different cell types within lymph nodes from patients with lymphadenopathy syndrome (LAS). 57
Constitutive activation of NF-kB and T-cell leukemia/lymphoma in Notch3 transgenic mice 57
High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. 57
Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma 57
Immunohistochemical heterogeneity of macrophage subpopulations in human lymphoid tissues. 56
HIV type 1 protease inhibitors enhance bone marrow progenitor cell activity in normal subjects and in HIV type 1-infected patients 56
CDKN2A/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach 56
Identification and expansion of the tumorigenic lung cancer stem cell population 55
Macrophage activation for tumor cytotoxicity: mechanisms of macrophage activation by lymphokines. 55
Evidence for neoplastic cell differentiation in mediastinal T lymphoblastic lymphoma. 55
Totale 7.086
Categoria #
all - tutte 32.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.306 0 0 0 0 0 0 346 286 282 196 135 61
2020/2021827 95 168 55 61 11 83 20 69 82 102 51 30
2021/20222.054 5 136 209 87 257 56 40 235 141 179 297 412
2022/20232.241 423 631 125 197 228 212 27 104 192 27 58 17
2023/2024728 56 114 22 47 49 83 18 53 1 102 99 84
2024/2025599 87 62 150 63 107 128 2 0 0 0 0 0
Totale 10.783